EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,256,866 | -1.0% | 2,428,490 | +114.1% | 0.03% | 0.0% |
| Q2 2023 | $8,337,987 | -14.7% | 1,134,420 | +20.2% | 0.03% | -18.4% |
| Q1 2023 | $9,776,318 | -1.1% | 943,660 | +12.7% | 0.04% | 0.0% |
| Q4 2022 | $9,889,222 | +33.7% | 837,360 | +137.5% | 0.04% | +18.8% |
| Q3 2022 | $7,399,000 | -12.4% | 352,500 | +29.6% | 0.03% | -5.9% |
| Q2 2022 | $8,445,000 | -15.4% | 272,060 | +11.8% | 0.03% | +6.2% |
| Q1 2022 | $9,988,000 | -0.2% | 243,260 | +5.7% | 0.03% | +3.2% |
| Q4 2021 | $10,008,000 | +32.2% | 230,230 | +52.2% | 0.03% | +29.2% |
| Q3 2021 | $7,572,000 | +256.8% | 151,230 | +322.5% | 0.02% | +166.7% |
| Q4 2018 | $2,122,000 | -32.2% | 35,794 | -24.7% | 0.01% | -18.2% |
| Q3 2018 | $3,130,000 | +76.1% | 47,548 | +35.1% | 0.01% | +57.1% |
| Q2 2018 | $1,777,000 | +73.0% | 35,192 | +80.4% | 0.01% | +75.0% |
| Q1 2018 | $1,027,000 | +13.4% | 19,507 | 0.0% | 0.00% | +33.3% |
| Q4 2017 | $906,000 | – | 19,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 22,111 | $908,000 | 2.08% |
| Global Alpha Capital Management Ltd. | 460,530 | $18,909,000 | 1.62% |
| AIMZ Investment Advisors, LLC | 70,625 | $2,900,000 | 1.19% |
| Bridge City Capital, LLC | 39,835 | $1,636,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 560,409 | $23,010,000 | 0.53% |
| EARNEST PARTNERS LLC | 2,071,376 | $85,051,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,721 | $12,430,000 | 0.50% |
| SummerHaven Investment Management, LLC | 14,476 | $594,000 | 0.34% |
| Ridgewood Investments LLC | 10,004 | $411,000 | 0.27% |
| AtonRa Partners | 11,505 | $472,000 | 0.26% |